S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
3 Defensive Stocks to Weather the Winter Storm
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
Floating Rate Bonds: The Retirement Play for 2021?
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
3 Defensive Stocks to Weather the Winter Storm
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
Floating Rate Bonds: The Retirement Play for 2021?
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
3 Defensive Stocks to Weather the Winter Storm
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
Floating Rate Bonds: The Retirement Play for 2021?
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
3 Growth Stocks with Market-Beating Potential
3 Defensive Stocks to Weather the Winter Storm
Why Your Prices Should Be More Like the Local Pizzeria
12 Leadership Lessons from Envoy Founder and CEO Larry Gadea
Floating Rate Bonds: The Retirement Play for 2021?
Log in
OTCMKTS:REMI

Remedent Earnings Date, Estimates & History

$0.15
-0.06 (-28.42 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.15
Now: $0.15▼
$0.15
50-Day Range
$0.15
MA: $0.19▼
$0.22
52-Week Range
$0.11
Now: $0.15▼
$0.43
Volume104 shs
Average Volume2,609 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-0.45

Earnings

Remedent has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 5th, 2021 based off prior year's report dates.

Remedent Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Remedent (OTCMKTS REMI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/5/2021
(Estimated)		       
2/14/2020Q3 2020($0.01)($0.01)$0.26 millionN/A
11/14/2019Q2 2020($0.01)($0.01)$0.24 millionN/A
2/14/2019Q3 2019($0.01)($0.01)$0.42 millionN/A
7/13/2018Q4 2018($0.01)($0.01)$0.49 millionN/A
6/29/2017Q4 2017$0.03$0.03$0.54 millionN/A
8/15/2016Q1 2017$0.01$0.01$0.62 millionN/A
6/29/2016Q4 2016($0.01)($0.01)$0.59 millionN/A
8/14/2015Q1 2016$0.01$0.01$0.83 millionN/A
7/14/2014Q4 2014$0.02$0.02$0.26 millionN/A
2/14/2014Q3 2014$0.01$0.01$0.87 millionN/A
7/15/2013Q4 2013$0.02$0.02$1.37 millionN/A
2/14/2013Q3 2013($0.02)($0.02)N/A
11/14/2012Q2 2013($0.03)($0.06)N/A
8/14/2012Q1 2013($0.04)($0.04)N/A
7/16/2012Q4 2012$0.02($0.03)N/A
2/21/2012Q3 2012($0.01)($0.01)N/A
11/21/2011Q2 2012($0.02)($0.02)N/A
8/15/2011Q1 2012($0.02)($0.02)N/A
7/14/2011Q4 2011($0.10)($0.10)N/A
8/16/2010Q1 2011$0.01$0.01N/A
11/17/2009Q2 2010($0.03)($0.04)($0.04)N/A
8/14/2009Q1 2010($0.02)($0.03)($0.03)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/4/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.